Negundonorin A exhibits significant anti-inflammatory and antioxidant properties, making it a candidate for development in therapeutic agents targeting chronic inflammatory diseases. It has shown inhibitory effects on pro-inflammatory cytokines, suggesting potential use in treating conditions like arthritis and inflammatory bowel disease. Additionally, its ability to modulate oxidative stress pathways may support its application in neurodegenerative disorders, where oxidative damage plays a key role. Preliminary studies also indicate antimicrobial activity against certain Gram-positive bacteria, opening avenues for its exploration in antimicrobial formulations. Due to its natural origin and bioactivity, it is being investigated as a lead compound in phytopharmaceuticals and nutraceuticals.